TERT c.228C>T ;(p.C76=)

Variant ID: 5-1294773-G-A

NM_198253.2(TERT):c.228C>T;(p.C76=)

This variant was identified in 7 publications

View GRCh38 version.




Publications:


Heterogeneity of the cancer cell line metabolic landscape.

Molecular Systems Biology
Shorthouse, David D; Bradley, Jenna J; Critchlow, Susan E SE; Bendtsen, Claus C; Hall, Benjamin A BA
Publication Date: 2022-11

Variant appearance in text: TERT: 228C>T
PubMed Link: 36321551
Variant Present in the following documents:
  • MSB-18-e11006-s010.xlsx, sheet 1
View BVdb publication page



Major Vault Protein (MVP) Associated With BRAF V600E Mutation Is an Immune Microenvironment-Related Biomarker Promoting the Progression of Papillary Thyroid Cancer via MAPK/ERK and PI3K/AKT Pathways.

Frontiers In Cell And Developmental Biology
Dong, Xubin X; Akuetteh, Percy David Papa PDP; Song, Jingjing J; Ni, Chao C; Jin, Cong C; Li, Huihui H; Jiang, Wenjie W; Si, Yuhao Y; Zhang, Xiaohua X; Zhang, Qiyu Q; Huang, Guanli G
Publication Date: 2021

Variant appearance in text: TERT: 228C>T
PubMed Link: 35433709
Variant Present in the following documents:
  • DataSheet1.xlsx, sheet 5
View BVdb publication page



Modulated Electro-Hyperthermia-Induced Tumor Damage Mechanisms Revealed in Cancer Models.

International Journal Of Molecular Sciences
Krenacs, Tibor T; Meggyeshazi, Nora N; Forika, Gertrud G; Kiss, Eva E; Hamar, Peter P; Szekely, Tamas T; Vancsik, Tamas T
Publication Date: 2020-08-29

Variant appearance in text: TERT: 228C>T
PubMed Link: 32872532
Variant Present in the following documents:
  • Main text
View BVdb publication page



"Reprogram Enablement" as an Assay for Identifying Early Oncogenic Pathways by Their Ability to Allow Neoplastic Cells to Reacquire an Epiblast State.

Stem Cell Reports
Kong, Yanjun Y; Gimple, Ryan C RC; McVicar, Rachael N RN; Hodges, Andrew P AP; Yin, Jun J; Liu, Yang Y; Zhan, Weiwei W; Snyder, Evan Y EY
Publication Date: 2020-09-08

Variant appearance in text: TERT: 228C>T
PubMed Link: 32795421
Variant Present in the following documents:
  • mmc2.pdf
  • mmc1.pdf
View BVdb publication page



Combinatorial Therapies in Thyroid Cancer: An Overview of Preclinical and Clinical Progresses.

Cells
Laetitia, Gheysen G; Sven, Saussez S; Fabrice, Journe J
Publication Date: 2020-03-30

Variant appearance in text: TERT: 228C>T
PubMed Link: 32235612
Variant Present in the following documents:
  • Main text
  • cells-09-00830.pdf
View BVdb publication page



GABPA-dependent down-regulation of DICER1 in follicular thyroid tumours.

Endocrine-Related Cancer
Paulsson, Johan O JO; Wang, Na N; Gao, Jiwei J; Stenman, Adam A; Zedenius, Jan J; Mu, Ninni N; Lui, Weng-Onn WO; Larsson, Catharina C; Juhlin, C Christofer CC
Publication Date: 2020-05

Variant appearance in text: TERT: 228C>T
PubMed Link: 32163919
Variant Present in the following documents:
  • Main text
  • ERC-19-0446.pdf
View BVdb publication page



Long-term vemurafenib treatment drives inhibitor resistance through a spontaneous KRAS G12D mutation in a BRAF V600E papillary thyroid carcinoma model.

Oncotarget
Danysh, Brian P BP; Rieger, Erin Y EY; Sinha, Deepankar K DK; Evers, Caitlin V CV; Cote, Gilbert J GJ; Cabanillas, Maria E ME; Hofmann, Marie-Claude MC
Publication Date: 2016-05-24

Variant appearance in text: TERT: 228C>T
PubMed Link: 27127178
Variant Present in the following documents:
  • oncotarget-07-30907-s001.pdf
View BVdb publication page